Harvard/Massachusetts General Hospital Medicine-Pediatrics Residency Program, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
J Gen Intern Med. 2018 Apr;33(4):463-470. doi: 10.1007/s11606-017-4227-3. Epub 2018 Jan 8.
Healthcare systems use population health management programs to improve the quality of cardiovascular disease care. Adding a dedicated population health coordinator (PHC) who identifies and reaches out to patients not meeting cardiovascular care goals to these programs may help reduce disparities in cardiovascular care.
To determine whether a program that used PHCs decreased racial/ethnic disparities in LDL cholesterol and blood pressure (BP) control.
Retrospective difference-in-difference analysis.
Twelve thousdand five hundred fifty-five primary care patients with cardiovascular disease (cohort for LDL analysis) and 41,183 with hypertension (cohort for BP analysis).
From July 1, 2014-December 31, 2014, 18 practices used an information technology (IT) system to identify patients not meeting LDL and BP goals; 8 practices also received a PHC. We examined whether having the PHC plus IT system, compared with having the IT system alone, decreased racial/ethnic disparities, using difference-in-difference analysis of data collected before and after program implementation.
Meeting guideline concordant LDL and BP goals.
At baseline, there were racial/ethnic disparities in meeting LDL (p = 0.007) and BP (p = 0.0003) goals. Comparing practices with and without a PHC, and accounting for pre-intervention LDL control, non-Hispanic white patients in PHC practices had improved odds of LDL control (OR 1.20 95% CI 1.09-1.32) compared with those in non-PHC practices. Non-Hispanic black (OR 1.15 95% CI 0.80-1.65) and Hispanic (OR 1.29 95% CI 0.66-2.53) patients saw similar, but non-significant, improvements in LDL control. For BP control, non-Hispanic white patients in PHC practices (versus non-PHC) improved (OR 1.13 95% CI 1.05-1.22). Non-Hispanic black patients (OR 1.17 95% CI 0.94-1.45) saw similar, but non-statistically significant, improvements in BP control, but Hispanic (OR 0.90 95% CI 0.59-1.36) patients did not. Interaction testing confirmed that disparities did not decrease (p = 0.73 for LDL and p = 0.69 for BP).
The population health management intervention did not decrease disparities. Further efforts should explicitly target improving both healthcare equity and quality. Clinical Trials #: NCT02812303 ( ClinicalTrials.gov ).
医疗保健系统采用人群健康管理计划来提高心血管疾病护理质量。在这些计划中增加专门的人群健康协调员(PHC),以识别和联系不符合心血管护理目标的患者,可能有助于减少心血管护理方面的差异。
确定使用 PHC 的计划是否降低了 LDL 胆固醇和血压(BP)控制方面的种族/民族差异。
回顾性差异差异分析。
12555 名患有心血管疾病的初级保健患者(LDL 分析队列)和 41183 名患有高血压的患者(BP 分析队列)。
从 2014 年 7 月 1 日至 2014 年 12 月 31 日,18 个实践使用信息技术(IT)系统来识别不符合 LDL 和 BP 目标的患者;8 个实践还配备了 PHC。我们通过比较实施计划前后收集的数据的差异差异分析,检查是否存在 PHC 加 IT 系统,与仅存在 IT 系统相比,是否减少了种族/民族差异。
符合指南的 LDL 和 BP 目标。
在基线时,在符合 LDL(p=0.007)和 BP(p=0.0003)目标方面存在种族/民族差异。比较有和没有 PHC 的实践,并考虑到干预前的 LDL 控制情况,与非 PHC 实践相比,PHC 实践中的非西班牙裔白人患者的 LDL 控制改善的可能性更高(OR 1.20,95%CI 1.09-1.32)。非西班牙裔黑人(OR 1.15,95%CI 0.80-1.65)和西班牙裔(OR 1.29,95%CI 0.66-2.53)患者的 LDL 控制也有类似但无统计学意义的改善。对于 BP 控制,PHC 实践中的非西班牙裔白人患者(与非 PHC 实践相比)有所改善(OR 1.13,95%CI 1.05-1.22)。非西班牙裔黑人患者(OR 1.17,95%CI 0.94-1.45)的 BP 控制也有类似但无统计学意义的改善,但西班牙裔患者(OR 0.90,95%CI 0.59-1.36)则没有。交互测试证实差异没有减小(p=0.73 用于 LDL,p=0.69 用于 BP)。
人群健康管理干预并未减少差异。应进一步努力明确提高医疗保健公平性和质量。临床试验 #: NCT02812303(ClinicalTrials.gov)。